Evidence map›Paper›PMID 22777948›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2012

A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis.

Pranita Katwa, Xiaojia Wang, Rakhee N Urankar, Ramakrishna Podila, Susana C Hilderbrand, Robert B Fick, Apparao M Rao, Pu Chun Ke, Christopher J Wingard, Jared M Brown

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Nanomaterials and Their Impact on the Immune System.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pranita KatwaDepartment of Pharmacology & Toxicology, East Carolina University, Greenville, NC 27834, USA.
Xiaojia Wang
Rakhee N Urankar
Ramakrishna Podila
Susana C Hilderbrand
Robert B Fick
Apparao M Rao
Pu Chun Ke
Christopher J Wingard
Jared M Brown

Funding

Mechanisms of non-IgE Mast Cell Activation by Environmental ParticulatesR01ES019311 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI BROWN, JARED MICHAEL · 2010 to 2024
$7.0M
Cardio-vascular Impact of Inhaled Multi-wall Carbon NanotubesR01ES016246 · NIEHS · EAST CAROLINA UNIVERSITY · PI WINGARD, CHRISTOPHER J · 2007 to 2010
$1.4M
NIEHS NIH HHS R01 ES016246NIEHS NIH HHS R01 ES019311
6 · The paper itself

Abstract

Concern about the use of nanomaterials has increased significantly in recent years due to potentially hazardous impacts on human health. Mast cells are critical for innate and adaptive immune responses, often modulating allergic and pathogenic conditions. Mast cells are well known to act in response to danger signals through a variety of receptors and pathways including IL-33 and the IL-1-like receptor ST2. Here, the involvement of mast cells and the IL-33/ST2 axis in pulmonary and cardiovascular responses to multi-walled carbon nanotube (MWCNT) exposure are examined. Toxicological effects of MWCNTs are observed only in mice with a sufficient population of mast cells and are not observed when mast cells are absent or incapable of responding to IL-33. Our findings establish for the first time that mast cells and the IL-33/ST2 axis orchestrates adverse pulmonary and cardiovascular responses to an engineered nanomaterial, giving insight into a previously unknown mechanism of toxicity. This novel mechanism of toxicity could be used for assessing the safety of engineered nanomaterials and provides a realistic therapeutic target for potential nanoparticle induced toxicities.

Indexed as

AnimalsFemaleInterleukin-1 Receptor-Like 1 ProteinInterleukin-33InterleukinsMast CellsMiceMice, Inbred BALB CNanotubes, CarbonReceptors, InterleukinIl1rl1 protein, mouseIl33 protein, mouseInterleukin-1 Receptor-Like 1 ProteinInterleukin-33InterleukinsNanotubes, CarbonReceptors, Interleukin

Identifiers

PMID22777948
PMCPMC3445726

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.